US Patent Application No: 2010/0255,007

THERAPEUTIC AGENTS FOR GRAFT-VERSUS-HOST DISEASE COMPRISING INTERLEUKIN 6 RECEPTOR INHIBITOR AS ACTIVE INGREDIENT

Stats

Oct 7, 2010
Publication date
Oct 1, 2008
filing date
12/733,951
serial no
Published
status

Importance

Loading Importance Indicators... loading....

Abstract

The present invention provides a novel therapeutic agent for graft-versus-host disease (GVHD).A therapeutic agent for graft-versus-host disease (GVHD), which comprises an interleukin 6 (IL-6) receptor inhibitor as an active ingredient.

Loading the Abstract Image... loading....

First Claim

loading....

Related Publications

Loading Related Publications... loading....

Patent Owner(s)

Patent Owner	Address	Total Patents
CHUGAI SEIYAKU KABUSHIKI KAISHA	TOKYO	558

International Classification(s)

[Classification Symbol]

[Patents Count]

Inventor(s)

Inventor Name	Address	# of filed Patents	Total Citations
Mihara, Masahiko	Gotenba, JP	12	101
Moriya, Yoichiro	Gotenba, JP	4	60

Patent Citation Ranking

Forward Cites

Patent Info	(Count)	# Cites	Year
CHUGAI SEIYAKU KABUSHIKI KAISHA (1)
8,398,980 Subtypes of humanized antibody against interleuken-6 receptor		0	2005

Maintenance Fees

Fee	Large entity fee	small entity fee	micro entity fee	due date
3.5 Year Payment	$1600.00	$800.00	$400.00	Apr 7, 2014
7.5 Year Payment	$3600.00	$1800.00	$900.00	Apr 7, 2018
11.5 Year Payment	$7400.00	$3700.00	$1850.00	Apr 7, 2022

Fee	Large entity fee	small entity fee	micro entity fee
Surcharge - 3.5 year - Late payment within 6 months	$160.00	$80.00	$40.00
Surcharge - 7.5 year - Late payment within 6 months	$160.00	$80.00	$40.00
Surcharge - 11.5 year - Late payment within 6 months	$160.00	$80.00	$40.00
Surcharge after expiration - Late payment is unavoidable	$700.00	$350.00	$175.00
Surcharge after expiration - Late payment is unintentional	$1,640.00	$820.00	$410.00